Intellect Neurosciences Inc. (fka ILNS)

[itwillgetbetter]

Its appears you are very good seeking info or are apart of the inner circle now and maybe always have been but good to know.

To me why no pr was issued this is one of (many) agreements the CEO has had to renegotiate since he began his task in mid 2014.

To me the key word other diseases is the key not to mention milestones,royalties that will have to be paid by ILNS and one can only assume when ILNS pays they will receive milestones or sales not just if FDA approved but a total sale of the company or a certain platform imo.

It also tells us that he has been negotiating with a top tier company to either licensee or sell this platform.

This agreement the wording is no different then ILNS writes regarding other diseases just like the licensee issued to Pfizer,Shire and whomever else they have outstanding agreements with all IMHO.

The licensee ILNS issues the wording in all license issued has other diseases defined in said contract you can bet on that again IMHO! To me it would be a standard in the Biotech industry cause if not one could sure miss a mother load of capital and no matter what anyone says about the CEO he knows every angle to skin a fat cat so to speak if possible.

Excuse the wording I love all animals,cats,dogs ect!